Analyst Ratings for Karuna Therapeutics Inc. (KRTX) [Buys]
KRTX Rating Summary
KRTX Price Target Summary
- Highest: $332.00 (Goldman Sachs)
- Lowest: $170.00 (BofA Securities)
- Average: $225.21
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$225.21 (-18.8%)
* Over Last 12-Mos
Rating Score: 9.4 / 10
Percentile Rank: 89%
Rating Score: 9.4 / 10
Percentile Rank: 89%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/2/2022 | JPMorgan | Jessica Fye | New Coverage | Overweight (N/A) |
175.00 (N/A) |
130.25 (277.42) |
112.99% | Details |
| 7/14/2022 | SVB Leerink | Marc Goodman | New Coverage | Outperform (N/A) |
170.00 (N/A) |
128.87 (277.42) |
115.27% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
